Tharman: S'pore will continue to invest in biomedical sector
Singapore
SINGAPORE will continue to invest to stay at the forefront of the biomedical sciences industry, even as the sector generated output of S$21.5 billion last year and employed 16,800 people, said Deputy Prime Minister Tharman Shanmugaratnam.
He made the point on Wednesday at a ground-breaking ceremony where drugmaker GlaxoSmithKline (GSK) said that it would set up a new global headquarters for Asia in Singapore, as it looks to the emerging markets to grow its business.
KEYWORDS IN THIS ARTICLE
BT is now on Telegram!
For daily updates on weekdays and specially selected content for the weekend. Subscribe to t.me/BizTimes
International
Xi tells Blinken US, China should be 'partners, not rivals'
Indonesia’s push for regional economic integration to continue under Prabowo: Vivian Balakrishnan
Outgoing Singapore, Indonesia leaders to hold their final retreat in Bogor on Apr 29
Beijing city to subsidise domestic AI chips, targets self-reliance by 2027
China passes tariff law as tensions with trading partners simmer
Blinken meets Chinese counterpart Wang Yi in Beijing